Supraglottic Airway Devices in Pediatric Difficult Airway Situations
NCT ID: NCT02572232
Last Updated: 2018-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2016-09-01
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glottic View Using Supraglottic Devices in Pediatric Patients
NCT02532465
Comparison of Endotracheal Intubation Over the Aintree Via the I-gel and Laryngeal Mask Airway Supreme
NCT02476565
Insertion of Different Supraglottic Airway Devices on Manikin
NCT05523752
A Comparison of the VBM Intubating Laryngeal Tube and the I-Gel
NCT03067246
Laryngeal Mask Supreme™ Versus the I-gel™
NCT00653237
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Combitube, Easytube, Laryngeal masks
Combitube, Easytube, Laryngeal mask airway are intubated in pediatric airway manikins by probands in randomized order.
Combitube, Easytube, Laryngeal masks
Supraglottic airway device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Combitube, Easytube, Laryngeal masks
Supraglottic airway device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* residents
* interns
* written informed consent form
Exclusion Criteria
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Frass
Univ.Prof.Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Frass, Prof. Dr.
Role: STUDY_CHAIR
Medical University of Vienna
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1805/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.